Maria L Srour, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 5165 Mccarty Ln, Lafayette, IN 47905 Phone: 765-448-8000 Fax: 765-448-7631 |
Salim S Abou Jaoude, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3920 St Francis Way Ste 220, Lafayette, IN 47905 Phone: 765-428-5950 Fax: 765-428-5951 |
John Charles Scanlon, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Salem St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7631 |
William G. Hutchison, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 |
Francis X Dillon, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5165 Mccarty Ln, Lafayette, IN 47905 Phone: 765-448-8000 Fax: 765-446-4695 |
Dr. Imad E. Khadra, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3920 St Francis Way Ste 220, Lafayette, IN 47905 Phone: 765-502-4110 Fax: 765-428-5951 |
Dr. Shahid Ahsan, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3920 St Francis Way Ste 220, Lafayette, IN 47905 Phone: 765-428-5950 Fax: 765-428-5951 |
News Archive
Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.
Implantable fibers have been an enormous boon to brain research, allowing scientists to stimulate specific targets in the brain and monitor electrical responses.
Restrictions against using brand names have rendered pharmaceutical Direct-to-Consumer Advertising (DTCA) in Europe an informative rather than promotional exercise. DTCA is now broadening its scope, evolving from its narrow publicity orientation to a more comprehensive approach focused on improved patient outcomes and value addition.
Programs that aim to curb teen prescription drug abuse have vastly differing effectiveness, ranging from big drops in drug abuse to no measurable effect, according to a new study of 11,000 teenagers by researchers at Duke and Pennsylvania State universities.
Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2011 and provided an update on several recent clinical and corporate developments.
› Verified 1 days ago